Inferior Immunotherapy Response When NSCLC Pts on Steroids Inferior Immunotherapy Response When NSCLC Pts on Steroids

In advanced non-small cell lung cancer (NSCLC), patients who use steroids when starting single-agent immunotherapy have inferior clinical responses with immunotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news